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Abstract: Vascular progenitor cells are desirable in a variety of therapeutic strategies; however, 
the lineage commitment of endothelial and smooth muscle cell from a common progenitor is not 
well-understood. Here, we report the generation of the first dual reporter mouse embryonic stem 
cell (mESC) lines designed to facilitate the study of vascular endothelial and smooth muscle devel-
opment in vitro. These mESC lines express green fluorescent protein (GFP) under the endothelial 
promoter, Tie-2, and Discomsoma sp. red fluorescent protein (RFP) under the promoter for 
alpha-smooth muscle actin (α-SMA). The lines were then characterized for morphology, marker 
expression, and pluripotency. The mESC colonies were found to exhibit dome-shaped morphol-
ogy, alkaline phosphotase activity, as well as expression of Oct 3/4 and stage-specific embryonic 
antigen-1. The mESC colonies were also found to display normal karyotypes and are able to 
generate cells from all three germ layers, verifying pluripotency. Tissue staining confirmed the 
coexpression of VE (vascular endothelial)-cadherin with the Tie-2 GFP+ expression on endothelial 
structures and smooth muscle myosin heavy chain with the α-SMA RFP+ smooth muscle cells. 
Lastly, it was verified that the developing mESC do express Tie-2 GFP+ and α-SMA RFP+ cells 
during differentiation and that the GFP+ cells colocalize with the vascular-like structures sur-
rounded by α-SMA-RFP cells. These dual reporter vascular-specific mESC permit visualization 
and cell tracking of individual endothelial and smooth muscle cells over time and in multiple 
dimensions, a powerful new tool for studying vascular development in real time.
Keywords: vascular progenitor cells, endothelial cells, smooth muscle cells, embryoid body, 
vasculogenesis
Introduction
Embryonic stem cells (ESC) are pluripotent cells that boast unlimited expansion 
potential in vitro and are able to differentiate into cells from all three germ layers.1 
Because ESC can be easily maintained and expanded in tissue culture systems, they 
are an excellent in vitro model for studying development and stem cell fate and as a 
cell source in cell transplantation therapies. Vascular progenitor cells are desirable in 
therapeutic strategies for patients exhibiting ischemic vascular disease,2 for coating 
of vascular grafts to inhibit platelet adhesion and clotting,3,4 and as vehicles for gene 
therapy as well as various tissue engineering applications.5
In the yolk sac of mammals, hematopoietic and endothelial lineage precursors 
differentiate into blood islands. The outer cells of the blood islands are endothelial, 
whereas the inner cells give rise to haematopoietic progenitors. These cells later become 
the primary vascular plexus. Within the embryo, angioblastic precursors aggregate into 
solid strands forming the ventral and dorsal aortas and vitelline arteries and veins. These 
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vascular systems are further remodeled through sprouting 
(angiogenesis), branching, and intussusception from existing 
blood vessels and specialize as arteries, veins, or capillaries 
(reviewed in6). Attempts to study vasculogenesis have led to 
the identification of a receptor for vascular endothelial growth 
factor (VEGF), called Flk-1, that is expressed on lateral plate 
mesodermal cells.7 Flk-1 is well-known as a prominent early 
differentiation marker for both endothelial cell (EC) and 
blood cells in the developing embryo and embryonic stem 
cell cultures.8–11
The development of EC and vascular smooth muscle cells 
(SMC) from a common Flk-1+ expressing progenitor cell has 
been previously established12 in a groundbreaking study. This 
work also showed that VEGF promoted EC differentiation 
while mural cells were induced by platelet-derived growth 
factor-BB and not by transforming growth factor-beta. 
However, despite a number of subsequent reports on the 
roles of various growth factors12–14 and extracellular matrix 
components15,16 in the specification of vascular cell fate, the 
complete signaling and regulatory mechanisms at the various 
stages of vascular cell induction remain incomplete.
Therefore, in order to better study vascular development 
in real time, we set out to develop a unique embryonic stem 
cell line that would express fluorescent proteins correspond-
ing with later stage SMC and EC commitment. We expect 
that this cell line will allow unique real time investigations 
of cell fate from single vascular progenitor cells as well as 
morphological development of blood vessels. We chose to 
use alpha-smooth muscle actin (α-SMA) as the molecular 
marker for SMC and Tie-2 as the marker for endothelial 
cells. Tie-2 is tyrosine kinase cell surface receptor that is 
activated by angiopoeitin binding. Tie-2 is present on both 
vascular EC and some hematopoietic cells17 and plays a 
role in regulating endothelial cell survival and blood vessel 
maturation.18
The transgenic mouse expressing RFP under the α-SMA 
promoter was developed by Dr David Allen Brenner19 and 
kindly donated for the generation of the dual fluorescent 
line. A transgenic mouse expressing GFP under the Tie-2 
promoter was generated by Motoike et al20 and purchased 
from Jackson Laboratories. The mice were bred and the 
blastocysts were isolated for the generation of the dual 
reporting vascular ESC lines. These dual reporter lines per-
mit the visualization of individual endothelial and smooth 
muscle cells within a population while also facilitating the 
temporal tracking of individual cells during morphological 
development.
Methods
Generation of embryos
This protocol was approved by the Institutional Animal Care 
and Use Committee (IACUC) of the University of California, 
Merced (Animal Welfare Assurance #A4561-01). A female 
mouse expressing GFP under Tie-2, (Tie-2 GFP; Jackson 
Laboratories) was mated with a male mouse expressing the 
Discomsoma sp. RFP under α-SMA RFP (from Dr Brenner, 
University of California, San Diego) and observed for a 
postcoital (pc) plug the following morning (Figure 1). The 
presence of a plug was considered day 0 of embryo develop-
ment. We then treated the pregnant mouse in order to delay 
the implantation (up to 8 days pc) of the developing blas-
tocysts using modified methods from previously published 
protocols.21–23 On day 2 pc, the pregnant female mouse was 
given an intraperitoneal injection of 10 µg of Tamoxifen 
(Sigma) dissolved in propylene glycol and a subcutaneous 
injection of 3 mg of Depo-Provera (Sigma) dissolved in 
phosphate buffered solution (PBS).
Extraction and isolation of the ESC
On day 7 pc, the female mouse was sacrificed by cervical 
dislocation. The uterine horns were removed and flushed with 
PBS and the blastocysts were collected (Figure 1) and plated 
in separate wells of a 12-well plate on mouse embryonic 
fibroblasts (MEF). The cells were initially fed ESC  Culture 
Medium consisting of Knockout Dulbecco’s Modified Eagle’s 
Medium (KO-DMEM) (Invitrogen) supplemented with 
15% fetal bovine serum (Invitrogen), 5% Knockout Serum 
Replacement (KSR) (Invitrogen), 1x nonessential amino acids 
(Invitrogen), 1x penicillin streptomycin, 1x L-glutamine, 
0.1 mM 2-mercaptoethanol (Calbiochem), and 1,000 units 
per 50 mL of leukemia inhibitory factor (Chemicon). After 
the first several passages, the cells were cultured in serum-free 
medium consisting of KO-DMEM (Invitrogen) supplemented 
with 15% KSR (Invitrogen), 1x nonessential amino acids 
(Invitrogen), 1x penicillin streptomycin, 1x L-glutamine, 
0.1 mM 2-mercaptoethanol (Calbiochem) and 2,000 units/mL 
of leukemia inhibitory factor (Chemicon), and 10 ng/mL of 
bone morphogenetic protein-4 (R&D Systems). The morphol-
ogy of the hatching blastocysts and the expansion of the inner 
cell mass (ICM) was observed each day for 4 days (Figure 1). 
The zona  pellucida is visible during day 0 and day 1 before the 
blastocyst firmly attaches to the MEF layer. After attachment 
at day 2, the trophoectoderm peeled away and the develop-
ing ICM became more prominent. After 4 days, the hatched 
blastocysts were flooded with 0.5x trypsin (Invitrogen) in 
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order to disaggregate the ICM. Once the ICM loosened into 
nonadherent cells (approximately 5–10 minutes of attentive 
observation under microscope), the solution was neutralized 
with ESC Culture Medium. The loosened ICM cells from 
each blastocyst were manually picked with an aspirator pipette 
system and transferred to individual MEF-coated plates and 
fed ESC Culture Medium. The developing ESC colonies were 
observed over the next 10 days with half medium changes 
occurring approximately every 4 days. After 10 days, the 
cells were maintained and expanded on MEF-coated dishes 
with full medium changes every other day. From one pregnant 
mouse, four lines of ESC were generated. Here we character-
ize two of the lines, named A3 and B2.
Karyotype analysis
ESC were cultured on mitotically inactivated mouse embry-
onic fibroblasts feeder layers and subsequently cultured 
on feeder-free 0.1% geletin-treated dishes prior to being 
treated with 10 uL/mL Karyo-MAX  colcemid (Gibco) 
for 60  minutes. ESC were washed with PBS, trypsinized, 
and  harvested. ESC pellets were resuspended in hypotonic 
 solution (75 mM KCl) for 7 minutes at 37°C, followed by 
fixation with Carnoy’s solution (3 volumes of methanol to 
1 volume of acetic acid) for 30 minutes. Fixed cells were con-
centrated and dropped onto an angled, humidified microscope 
slide. The slide was washed with 1 mL of fixation solution 
to clean up the debris and subsequently dried. The chromo-
somes were stained with Hoechst dye (1:1,000 dilution) for 
60 minutes at room temperature in the dark and imaged with 
an Olympus fluorescence microscope.
Characterization of ESC
The ESC-like colonies were analyzed for 3-D morphology on 
MEF layers. Cells were also treated with 0.7% Triton X-100 
(MP Biomedicals, LLC) to permeabilize the cells and stained 
with alkaline phosphatase (Cell Biolabs) per the manufac-
turer’s instructions. Images of stained cells were taken with an 
inverted phase contrast microscope. ESC-A3 (passage #12) 
and ESC-B2 (passages #11) were also plated in a twelve-well 
dish coated with MEF at a concentration of 10,000 cells 
Female: Tg (Tie2GFP) 287Sato/JGFP
              (Jackson Labs)
Day 7 pc:
Sacrifice the female
and isolate the
uterine horn
Plate blastocysts onto
embryonic mouse
fibroblasts
Day 0 Day 1 Day 2 Day 3 Day 4
ICM
Isolated four mESC lines from
six blastocytes =66% efficiency
Male: C57BL/6-Tg (alpha SMA-RFP)
(donated from Dr Brenner, UCSD)
X
Figure 1 Flow chart of methodology for establishing the new mESC lines.
Notes: On day 0, the mice were bred together, and pregnancy was verified the following day by the presence of plug. At day 2, the implantation of embryo was delayed by 
injecting a pregnant female with 10 µg tamoxifen and 3 mg of Depo-Provera. After 7 days, the pregnant female was euthanized. The delayed blastocysts were then isolated, 
by flushing uterine horn, and plated on embryonic fibroblast feeder cells. From days 7–11 (days 0–4 after plating the blastocysts), each blastocyst hatched to reveal its ICM. 
Images of the blastocysts after plating include a collected blastocyst at day 0, the blastocyst attached to the supportive fibroblast feeder layer with zona pellucida at day 1, 
the trophoectoderm beginning to peel away from the blastocyst at day 2, and the ICM developing from days 2–4. By day 4, the ICM was developed enough to be manually 
selected from each hatching blastocyst, disassociated into individual cells, and replated. Scale =50 µm.
Abbreviations: mESC, mouse embryonic stem cell; ICM, inner cell mass; SMA, smooth muscle actin; RFP, red fluorescence protein; UCSD, University of California, San 
Diego; pc, post-coital.
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per well. ESC were allowed to establish well-defined colonies. 
After 4 days, the cells were fixed with 4% paraformaldehyde 
and stained with rabbit anti-mouse Nanog (Cell Signalling) 
and Sox 2 (Abcam), biotinylated stage-specific embryonic 
antigen-1, and Oct3/4 PE. The primary antibodies were 
allowed to incubate overnight in PBS with 1mg/mL BSA, 
5% donkey serum, 0.7% triton x-100 (except the biotiny-
lated antibody) and counterstained with donkey anti-rabbit 
FITC (Abcam) for Sox-2, donkey anti-rabbit Alexaflour 488 
(Invitrogen) for Nanog, or streptavidin FITC (Fitzgerald) 
for approximately 2 hours at room temperature. Cells were 
visualized using either a Nikon TE 2000 fluorescent micro-
scope (Technical Instruments) or a Laser Scanning Confocal 
Microscope (Technical Instruments).
Tumor assay for pluripotency
Severely immune-compromised NOD/SCID IL2 receptor 
gamma chain knockout (NSG) mice (Jackson Laboratories) 
were injected with 1 million ESC in 100 µL of PBS subcuta-
neously in the dorsal flanks of each mouse using a 28 gauge 
needle. After 30 days, the mice were euthanized by cervical 
dislocation and the teratomas harvested and sent out for histo-
logical processing (IDEXX Laboratories). The prepared slides 
were then dehydrated in graded alcohol, de-paraffinized using 
three washes of xylene, then rehydrated in graded alcohol 
and placed in PBS until imaging with a confocal microscope. 
After deparaffinization, the GFP and RFP were either directly 
visualized, or counterstained in 1% BSA (Sigma), 5% donkey 
serum (Fitzgerald), 0.7% Triton X-100 (MP Biomedical) 
followed by a goat anti-DsRed antibody (Santa Cruz, 1:50 
dilution) followed by donkey-anti goat PE (Abcam, 1:100 
dilution). DAPI (4′,6-Diamidino-2-Phenylindole, Dilactate) 
was used to visualize the nuclei and images were taken on a 
Nikon TE 2000 fluorescent microscope. To verify endothe-
lial and smooth muscle cell identity, goat anti-VE (vascular 
endothelial)-cadherin (Santa Cruz, 1:100) with a donkey anti-
goat (Santa Cruz, 1:100) or rabbit anti-smooth muscle myosin 
heavy chain (Abcam, 1:50) with a donkey anti-rabbit FITC 
(Abcam, 1:50) was also used in conjunction with the direct 
visualization of the GFP or the counter stained RFP.
Analysis of 3D sprouting  
vascular-like structures
ESC were plated in tissue culture plates to deplete the MEF 
population as described above, then resuspended in medium 
consisting of alpha-Minimal Essential Medium (Cellgro), 
20% fetal bovine serum, 1x penicillin-streptomycin, and 
50 µg/mL of VEGF (R&D Systems). The mESC were then 
allowed to aggregate into embryoid bodies (EB) at approxi-
mately 1,000 cells per aggregate using the hanging drop 
method. After 1 day, the mESC aggregates were rinsed into 
a 60 mm2 ultra low adhesion plates (Corning). Between days 
7 and 8, each EB was sandwiched between Matrigel drops 
(400 µL total) on a glass bottom dish (MatTek). Imaging 
of EB sprouting was performed over time (days 7, 10, 14, 
18, and 21) using a Laser Scanning Confocal microscope 
(Technical Instruments).
Differentiation of ESC into mesoderm
A3 and B2 ESC were plated at 10,000 cells/cm2 on 50 ng/mL of 
collagen IV-coated or fibronectin-coated plates (BD  Biosciences) 
and cultured in Stage 1 Differentiation Medium, called 
NSD12b, for A3 and B2, respectively.24 Briefly, our serum-free 
Stage 1 Differentiation Medium, preoptimized for B2 and A3 
cells included alpha-DMEM (Invitrogen), 15% KSR (Invitro-
gen), 1x penicillin-streptomycin (Invitrogen), 1x nonessential 
amino acids (Invitrogen), 2 mM L-glutamine (Invitrogen), 
0.1 mM 2-mercaptoethanol (Calbiochem), 5 ng/mL of bone 
morphogenetic protein-4 (R&D Systems) and 0 or 20 ng/mL 
of VEGF (R&D Systems) for A3 and B2, respectively. At 0, 
1, 2, 3, and 4 days, the cells were collected and stained for 
upregulation of mesoderm marker, Flk-1, and downregulation 
of pluripotent stem cell marker, Oct3/4. Briefly, cells were 
fixed 4% paraformaldehyde overnight before being placed in 
a solution of 1% bovine serum albumin (BSA) (Sigma), 0.7% 
Triton X-100 (MP Biomedicals LLC), and 5% donkey serum 
(Fitzgerald) for 1 hour prior to staining. Cells were stained with 
Alexa Fluor 647 anti-mouse Flk-1 (Biolegend), or anti-Oct3/4 
PE conjugated antibody (Becton Dickinson [BD]) overnight. 
Cells were rinsed and analyzed on an LSR II flow cytometer 
(BD). All results were gated to 5% of an isotype control.
Fluorescence tracking during 
differentiation
A3 mESC were plated at 10,000 cells/cm2 on 50 ng/mL 
 fibronectin-coated plates (BD Biosciences) and cultured in 
Stage 1 Differentiation Medium.24 After 3 days, the cells 
were replated at 10,000 cells/cm2 on 50 ng/mL fibronectin-
coated plates and cultured in Stage 2 Differentiation Medium 
containing 70% alpha-MEM (Mediatech) and 30% DMEM 
(Invitrogen) plus 2x Nutridoma CS (Roche), 1x penicillin-
streptomycin (Invitrogen), 1x nonessential amino acids 
(Invitrogen), 2 mM L-glutamine (Invitrogen), and 0.05 mM 
2-mercaptoethanol (Calbiochem), 10 ng/mL basic Fibroblast 
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Growth Factor (Sigma), and 10 ng/mL VEGF (R&D Systems). 
On days 5, 7, 10, 12, and 14 of total differentiation, the dif-
ferentiating cells were removed using Cell Dissociation Buffer 
(Invitrogen) for 30–60 minutes and analyzed for Tie-2 GFP 
or α-SMA RFP expression on an Aria III Flow Cytometer 
(BD). Data analyses were performed using FlowJo software 
(Tree Star Inc.). FITC- and PE-labeled compensation beads 
were used for compensation of potentially double positive 
cells. Unstained and undifferentiated A3 mESC were used as 
a negative control and gated to ,5% of the negative control. 
Fluorescent populations of cells were analyzed for statistical 
significance using one-way analysis of variance and a post hoc 
Tukey’s HSD test using the R programming language.
Results
Characterization of mESC
Out of the original 6 blastocysts that were isolated from one 
pregnant mouse, 4 resulted in embryonic stem cell lines, that is, 
greater than 50% efficiency (Figure 1). These exhibited typical 
3-D colony-like morphology, expressed high levels of alkaline 
phosphatase activity (Figure 2A and B) and retained  normal 
mouse karyotype of 40 chromosomes ( Figure 2C and D). 
The mESC lines also express pluripotent stem cell markers 
Oct 3/4 transcription factor (Figure 2E and F), stage-specific 
embryonic antigen-1 (Figure 2G and H), as well as Sox-2 
(Figure 2I and J) and Nanog (Figure 2K and L).
Mouse ESC generate cells from  
all three germ layers
In order to verify the pluripotency of the new ESC lines, ESC 
were injected into the dorsal hind flank of NSG knockout 
mice to assay for teratoma formation. Differentiated tissue 
from both A3 and B2 mESC lines were able to form tissues 
from all three germ layers including digestive (Figure 3A) 
and secretory endoderm (Figure 3D), pacinian corpuscles 
indicating ectodermal lineage (Figure 3B and E), and an 
abundance of skeletal (Figure 3C) and cardiac muscle 
(Figure 3F) mesoderm tissue.
Mouse ESC fluorescent markers express 
in the corresponding cell phenotype
Within both tissues, Tie-2 GFP+ cells and α-SMA 
RFP+ cells were present and interacting with each other 
(Figure 3G and H). In order to verify specificity of the 
A3
A
C D
B
E F
HG
I J
LK
Oct 3/4 Oct 3/4
SSEA-1SSEA-1
Sox-2 Sox-2
NanogNanog
B2
A3 B2
Figure 2 ESC stain positive for markers consistent with undifferentiated stem cells.
Notes: (A and B) The A3 and B2 ESC lines, respectively, display typical ESC colony morphology and display high levels of alkaline phosphatase activity. (C and D) A3 and B2 
ESC cell lines display normal karyotypes with 40 chromosomes each. (E–L) A3 and B2 mESC display typical ESC colony morphology and markers: (E and F), Oct 3/4 (red); 
(G and H), SSEA-1 (green); (I and J), Sox-2 (green); and (K and L), Nanog (green), respectively. All cells are counterstained with DAPI. Scale bars =100 µm.
Abbreviations: DAPI, 4′,6-diamidino-2-phenylindole; ESC, embryonic stem cells; SSEA-1, stage-specific embryonic antigen-1.
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reporter genes, the histology slides from the teratomas were 
stained for VE-cadherin or smooth muscle-myosin heavy 
chain (SM-MHC). Both the A3 and B2 cell lines exhibited the 
endothelial specific marker, VE-cadherin (Figure 4A and D), 
colocalized with Tie-2 GFP (Figure 4B and E). An overlay of 
the two images confirms dual expression (Figure 4C and F). 
Similarly, the expression of the mature smooth muscle cell 
marker, SM-MHC, was detected (Figure 4G and J) with 
α-SMA RFP expression (Figure 4H and K). Merging of the 
images localizes expression to a strip of smooth muscle cells 
(Figure 4I) as well as a pacinian corpuscle (Figure 4L).
Differentiated ESC generate  
vascular structures
In order to validate that the new mESC lines expressed 
both reporters during differentiation, EB were generated 
from both mESC lines. The A3 stem cell line expressed the 
Tie-2 GFP fluorescent reporter as early as day 7 (Figure 5A) 
with  interconnected networks at day 10 (Figure 5B). This is 
 consistent with embryogenesis, where Tie-2 is first detectable 
on day 8, with widespread expression by day 9.5.20  Individual 
α-SMA RFP+ cells were observed within sprouting EB at days 
14 and 18 (Figure 5C and D, respectively, and Video S1A). 
In contrast, the B2 EB formed a large Tie-2-GFP+ networks 
at day 10 that were maintained through day 14. By day 18, 
the structures appear to have been remodeled into smaller 
capillary-like structures with more α-SMA RFP+ cells sur-
rounding the structures with some regression seen by day 21 
(Figure 5E–H and Video S1B).
Temporal development of mesoderm 
differentiating in monolayer cultures
The differentiation of ESC into EC is performed in two 
distinct stages, as previously published24: ESC differentiate 
into Flk-1+ progenitor cells in our Stage 1  Differentiation 
Medium, then the Flk-1+ cells are replated in Stage 2 
 Differentiation Medium (Figure S1). The vascular progeni-
tor cell marker, Flk-1, expression for both the A3 and B2 
B2
A3
A B C
FED
G H
Endoderm Ectoderm Mesoderm
Figure 3 A3 and B2 ESC cell lines differentiate into cells from the three germ layers within teratomas.
Notes: Tumor assays of (A–C) A3-ESC exhibiting endoderm, ectoderm, and mesoderm, respectively. (D–F) B2-ESC exhibiting endoderm, ectoderm, and mesoderm, 
respectively. The selected A3-ESC images show (A) elongated columnar cells (acinar epithelium) with dark cytoplasm of the digestive organs. (B) The circular structure near 
the bottom is dermis sensory tissue consistent with the onion-like Pacinian corpuscle. (C) The circular structures closely resemble myofibrils of skeletal muscle. The B2-ESC 
developed (D) exocrine cells containing nuclei surrounded by small, cuboidal, uniformly dark stained cytoplasm. This is a defining characteristic of serous acini cells found in 
the secretory tissue. The B2-ESC tumors also developed (E) Pacinian corpuscles and (F) a region of cardiac muscle (dotted circle) with clearly defined sarcomere structures. 
Teratomas also display Tie-2 GFP+ and α-SMA RFP+ cells interacting with each other. (G) A3-ESC formed tissue resembling a lymph follicle with developing cells weakly 
expressing Tie-2 GFP+ surrounded by α-SMA RFP+ cells and strongly Tie-2 GFP+ cells that form venule-like structures. (H) B2-ESC form layers of α-SMA RFP+ cells that appear 
to be similar to the dermis sensory tissue of a pacinian corpuscle and are infiltrated with Tie-2 GFP+ cells that are indicative of small blood vessels. Scale bars =100 µm.
Abbreviations: α-SMA, alpha-smooth muscle actin; ESC, embryonic stem cells; GFP, green fluorescent protein; RFP, red fluorescent protein.
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A3
A
Day 7 Day 10 Day 14 Day 18
Day 21Day 18Day 14Day 10
B C D
HGFE
B2
Figure 5 Embryoid bodies (EB) develop vascular Tie-2 GFP+ and α-SMA RFP+ cells.
Notes: The differentiating EB of (A–D) A3-ESC and (E–H) B2-ESC from day 7 through 21. The Tie-2 expression under a GFP promoter is first observed at day 7 for A3 and day 10 
for B2, followed by α-SMA RFP cells surrounding the structures. Note that by day 18 and 21 for A3 and B2, respectively, the larger vessel-like structures appear to be remodeled into 
smaller, more compact vessel structures. The subtle differences in expression patterns are most likely due to inherent differences between the mESC lines. Scale bars =50 µm.
Abbreviations: α-SMA, alpha-smooth muscle actin; ESC, embryonic stem cells; GFP, green fluorescent protein; mESC, mouse embryonic stem cell; RFP, red fluorescent protein.
A3
VE-cadherin
SM-MHC α-SMA RFP
Tie-2 GFP Overlay
Overlay
B2
A3
B2
J K L
IHG
D E F
CBA
Figure 4 A3 and B2 ESC cell lines coexpress fluorescent proteins and markers of mature EC and SMC within teratomas.
Notes: (A–F) VE-cadherin+ (red) cells form vessel-like structures and colocalize with the Tie-2 GFP cells for A3 and B2 mESC lines. (G–L) Likewise, SM-MHC+ cells (green) 
are coexpressed with the α-SMA RFP cells in both mESC lines. All cells were counterstained with DAPI (blue). Scale bars =100 µm.
Abbreviations: α-SMA, alpha-smooth muscle actin; GFP, green fluorescent protein; RFP, red fluorescent protein; SM-MHC, smooth muscle myosin heavy chain; VE, vascular 
endothelial; ESC, embryonic stem cells; mESC, mouse ESC; VE, vascular endothelial.
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ESC lines was followed over an initial 4 days. Both cell 
lines expressed the greatest percentage of Flk-1+ cells at 
day 3 of induction (Figure S2). The upregulation of Flk-1+ 
cells also coincided with a corresponding decrease in Oct 
3/4 expression (Figure S2). Using Stage 2 Differentiation 
Medium, we then examined the GFP and RFP expression 
of differentiating A3-ESC over time (Figure 6A and B). The 
expression of both of these Tie-2 GFP+ and α-SMA RFP+ 
vascular cells was first observed in monolayer cultures and 
then quantified by fluorescence activated cell sorting analysis 
from day 5 (2 days after plating the Flk-1+ cells) through day 
14 of total differentiation. The Tie-2 GFP+ cells were first 
observed at day 5, slightly earlier than the 3-D EB method 
of differentiation in which the Tie-2+ vascular-like structures 
first emerged at day 7. The α-SMA RFP+ was also observed 
on the early mesodermal cells, peaking at day 10, the same 
time as the Tie-2 GFP+ cells.
Conclusion
In these mouse ESC lines, the expression of GFP indicates 
EC commitment while RFP identifies the emerging smooth 
muscle cells. To our knowledge, there is not another ESC 
line that currently identifies both vascular EC and SMC. 
This unique system was specifically designed to allow real-
time studies of vascular stem cell fate from stem cell popu-
lations or single cells because these cells do not require 
fixation in order to track their developmental progress. The 
RFP expression in SMC, which do not express unique cell 
surface markers, may also provide an additional “handle” 
for fluorescence activated cell sorting SMC from other 
differentiating cell types. Our 2-D and 3-D differentiation 
systems both show expression of Tie-2+ and α-SMA+ cells 
at day 7 and increase up to days 18 to 21 of differentiation, 
indicating a closely related temporal development.
It is also important to note that these markers are excel-
lent, but still not completely definitive for endothelial and 
vascular smooth muscle. The α-SMA is also expressed 
in early embryonic cardiac cells and Tie-2 is expressed 
on hematopoietic cells. Therefore, the differentiation and 
isolation of these cells was monitored in conjunction with 
morphology and/or differentiation kinetics of the system. 
Despite this drawback, these cells provide an improved 
model for directing vascular fate in conjunction with 
morphological development of the vasculature in a 3-D 
system.
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Figure 6 Quantification of temporal expression of Tie-2 GFP+ and α-SMA RFP+ cells differentiating as monolayer cultures.
Notes: The Flk-1+ cells were re-plated as monolayers and allowed to differentiate overtime. The (A) Tie-2 GFP+ and (B) α-SMA RFP+ cells were then quantified as a function 
of time. Note that the first observed expression is seen at day 5, slightly earlier than the EB differentiation methods. *P,0.05 and #P,0.01, N$3 distinct experiments.
Abbreviations: Avg, average; α-SMA, alpha-smooth muscle actin; GFP, green fluorescent protein; RFP, red fluorescent protein.
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Figure S2 The ESC marker Oct 3/4 declines as ESC differentiate.
Note: Under optimal conditions for differentiation of ESC to Flk-1+ cells, Oct 3/4 undergoes a marked decrease from day 2 to day 3, as Flk-1 expression peaks and is 
sustained in both A3 and B2 mESC.
Abbreviations: ESC, embryonic stem cells, mESC, mouse ESC.
Supplementary materials
Video S1 The videos contain the Z-stacked images of the developing vascular structures within embryoid bodies from (A) A3 and (B) B2 ESC, respectively.
Abbreviation: ESC, embryonic stem cells.
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Figure S1 Flow chart of the stage-specific differentiation used to obtain mature ESC-EC in chemically defined conditions.
Notes: Stage 1 was optimized for the induction of ESC towards mesoderm, specifically Flk-1+ vascular progenitor cells. Stage 2 induces further differentiation of the Flk-1+ 
cells into vascular cell derivatives.
Abbreviations: bFGF, basic fibroblast growth factor; BMP-4, bone morphogenetic protein-4; EC, endothelial cell; ESC, embryonic stem cells; LIF, leukemia inhibitory factor; 
VEGF, vascular endothelial growth factor; w/, with.
